[Drug interactions in neurosurgical patients].
Autor: | Baranich AI; Burdenko Neurosurgical Center, Moscow, Russia.; Plekhanov Russian Economic University, Moscow, Russia., Sychev AA; Burdenko Neurosurgical Center, Moscow, Russia., Savin IA; Burdenko Neurosurgical Center, Moscow, Russia., Kudrina VG; Plekhanov Russian Economic University, Moscow, Russia.; Russian Medical Academy of Continuing Professional Education, Moscow, Russia. |
---|---|
Jazyk: | English; Russian |
Zdroj: | Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko [Zh Vopr Neirokhir Im N N Burdenko] 2023; Vol. 87 (6), pp. 100-105. |
DOI: | 10.17116/neiro202387061100 |
Abstrakt: | We analyzed literature data on the most common drug interactions in neurosurgical patients. Drug interactions are a potential cause of adverse and dangerous clinical events and outcomes. Awareness of nature of drug interactions is valuable to avoid negative consequences when using combination of several drugs. Polypharmacy in neurosurgical patients is caused by treatment of intracranial lesions (hormonal therapy, antiepileptic drugs, etc.) and concomitant somatic diseases that increases the risk of drug interactions. |
Databáze: | MEDLINE |
Externí odkaz: |